TTD | Drug: D0Q0LD

Drug General Information
Drug ID	D0Q0LD
Former ID	DNC007825
Drug Name	NEODYSIDENIN
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529029]
Structure		Download 2D MOL 3D MOL
Formula	C17H23Cl6N3O2S
Canonical SMILES	CC(CC(C(=O)N(C)C(C)C1=NC=CS1)NC(=O)CC(C)C(Cl)(Cl)Cl)C(C<br />l)(Cl)Cl
InChI	1S/C17H23Cl6N3O2S/c1-9(16(18,19)20)7-12(25-13(27)8-10(2)17(21,22)23)15(28)26(4)11(3)14-24-5-6-29-14/h5-6,9-12H,7-8H2,1-4H3,(H,25,27)/t9-,10-,11+,12-/m0/s1
InChIKey	MBVQTLXBQHZLRO-YFKTTZPYSA-N
PubChem Compound ID	15482063
Target and Pathway
Target(s)	Arachidonate 12-lipoxygenase, 12S-type	Target Info	Inhibitor	[529029]
BioCyc Pathway	Lipoxin biosynthesis
KEGG Pathway	Arachidonic acid metabolism
	Metabolic pathways
	Serotonergic synapse
	Inflammatory mediator regulation of TRP channels
PANTHER Pathway	Inflammation mediated by chemokine and cytokine signaling pathway
PathWhiz Pathway	Arachidonic Acid Metabolism
WikiPathways	Arachidonic acid metabolism
WikiPathways	Eicosanoid Synthesis
References
Ref 529029	Bioorg Med Chem. 2007 Nov 15;15(22):6900-8. Epub 2007 Aug 22.Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.
Ref 529029	Bioorg Med Chem. 2007 Nov 15;15(22):6900-8. Epub 2007 Aug 22.Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information